Last reviewed · How we verify

NCT06725849

Barriers to Physical Activity in Familial Mediterranean Fever

Not yet recruiting Last updated 10 December 2024
What this trial tests

trial in Familial Mediterranean Fever (FMF ) in 100 participants. Not yet recruiting.

Timeline
16 December 2024
Primary endpoint
16 December 2025
16 December 2025

Quick facts

Lead sponsorIstanbul University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment100
Start date16 December 2024
Primary completion16 December 2025
Estimated completion16 December 2025
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Istanbul University

Who can join

Adults 18 to 65, any sex, with Familial Mediterranean Fever (FMF ). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project is a 2209-A TÜBİTAK project. It has been developed to identify the barriers to physical activity among patients diagnosed with Familial Mediterranean Fever (FMF). The project aims to determine the problems encountered by FMF patients when engaging in physical activity and the reasons behind these issues, using various assessment methods to identify the reasons for avoiding physical activity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Familial Mediterranean Fever (FMF )

Currently open trials in the same condition.

Other Istanbul University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06725849.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing